scholarly journals Thyroid stimulating hormone and free triiodothyronine are valuable predictors for diabetic nephropathy in patient with type 2 diabetes mellitus

2018 ◽  
Vol 6 (15) ◽  
pp. 305-305 ◽  
Author(s):  
Xianming Fei ◽  
Mingfen Xing ◽  
Mingyi Wo ◽  
Huan Wang ◽  
Wufeng Yuan ◽  
...  
2018 ◽  
Vol 56 (4) ◽  
pp. 431-440 ◽  
Author(s):  
T. I. de Vries ◽  
◽  
L. J. Kappelle ◽  
Y. van der Graaf ◽  
H. W. de Valk ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Yunzhao Tang ◽  
Tiantian Yan ◽  
Gang Wang ◽  
Yijun Chen ◽  
Yanjuan Zhu ◽  
...  

Objective. The present study explored the association between insulin resistance (IR) and the clinical characteristics of thyroid nodules in patients with type 2 diabetes mellitus (T2DM).Methods. All the patients were newly diagnosed with T2DM. 201 patients with thyroid nodule disease and 308 patients without the nodular thyroid disease. The participants were evaluated by relevant examination. Correlation analyses and regression analyses were performed to examine the relationships between the two groups.Results. HOMA-IR values, serum FT4 (free thyroxine) levels, and age were higher in the thyroid nodule group than in the control group. The proportion of women in the thyroid nodule group is greater than the proportion of women in the control group. Logistic regression analysis showed that age, sex, FT4, and HOMA-IR were positive factors for thyroid nodule. The volume and size of the thyroid nodule were positively correlated with HOMA-IR, irrespective of gender. The thyroid nodule volume and size and the TSH (thyroid stimulating hormone) were greater in females than in males, whereas FT3 (free triiodothyronine) was lower in females.Conclusion. IR might be a risk factor for thyroid nodule. Whether alleviating the IR might slow the growth, or diminish the volume and size of the thyroid nodules, is yet to be elucidated.


2014 ◽  
Vol 186 (15) ◽  
pp. 1138-1145 ◽  
Author(s):  
Jean-Pascal Fournier ◽  
Hui Yin ◽  
Oriana Hoi Yun Yu ◽  
Laurent Azoulay

2021 ◽  
pp. 239936932098478
Author(s):  
Joana Marques ◽  
Patrícia Cotovio ◽  
Mário Góis ◽  
Helena Sousa ◽  
Fernando Nolasco

Diabetic nephropathy is a well known complication of diabetes mellitus and the leader cause of end -stage renal disease worldwide. Nonetheless, other forms of renal involvement can occur in diabetic population. Since it has prognostic and therapeutic implications, differentiating non-diabetic renal disease from diabetic nephropathy is of great importance. We report an 80-year-old man with well-controlled type 2 diabetes mellitus and hypertension, who presented with rapid deterioration of renal function, nephrotic proteinuria, microscopic hematuria and leukocyturia. The atypical clinical presentation prompted us to perform a kidney biopsy. A diagnosis of proliferative glomerulonephritis with monoclonal immunoglobulin deposits (light chain only variant) was made, with however some chronic histological aspects which made us took a conservative therapeutic attitude. We emphasize that other causes of chronic proteinuric kidney disease should be considered in patients with type 2 diabetes mellitus, based on clinical suspicion, absence of other organ damage and mostly if an atypical presentation is seen. We review the spectrum of monoclonal gammopathies of renal significance, focusing on this rare and newly describe entity.


Metabolism ◽  
2004 ◽  
Vol 53 (11) ◽  
pp. 1395-1398 ◽  
Author(s):  
Kiyoko Nawata ◽  
Motoi Sohmiya ◽  
Mikiko Kawaguchi ◽  
Masateru Nishiki ◽  
Yuzuru Kato

Sign in / Sign up

Export Citation Format

Share Document